Acute lymphocytic leukaemia recurrent and Ideational apraxia

Summary:

Ideational apraxia is found among people with Acute lymphocytic leukaemia recurrent, especially for people who are male, 30-39 old.

The study analyzes which people have Ideational apraxia with Acute lymphocytic leukaemia recurrent. It is created by eHealthMe based on reports of 10 people who have Acute lymphocytic leukaemia recurrent from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 29, 2023

10 people who have Acute Lymphocytic Leukaemia Recurrent and Ideational Apraxia are studied.


What is Acute lymphocytic leukaemia recurrent?

Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent) is found to be associated with 340 drugs and 158 conditions by eHealthMe.

What is Ideational apraxia?

Ideational apraxia (neurological disorder -difficulty with actions requiring planning) is found to be associated with 1,015 drugs and 839 conditions by eHealthMe.

Number of Ideational apraxia in Acute lymphocytic leukaemia recurrent reports submitted per year:

Would you have Ideational apraxia when you have Acute lymphocytic leukaemia recurrent?

Gender of people who have Acute Lymphocytic Leukaemia Recurrent and experienced Ideational Apraxia *:

  • female: 20 %
  • male: 80 %

Age of people who have Acute Lymphocytic Leukaemia Recurrent and experienced Ideational Apraxia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 80 %
  • 40-49: 0.0 %
  • 50-59: 20 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Central Nervous System Leukaemia (cancer of central nervous system): 7 people, 70.00%
  2. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 20.00%
  3. Fungal Infection: 2 people, 20.00%
  4. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 10.00%

Common drugs taken by these people *:

  1. Blincyto: 2 people, 20.00%
  2. Ambisome: 1 person, 10.00%

Common symptoms for these people *:

  1. Speech Impairment (Adult) (inability to speak (adult)): 8 people, 80.00%
  2. Personality Change Due To A General Medical Condition: 8 people, 80.00%
  3. Leukoencephalopathy (disease of the white matter in the brain): 8 people, 80.00%
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 8 people, 80.00%
  5. Dementia (madness): 8 people, 80.00%
  6. Memory Loss: 2 people, 20.00%
  7. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 2 people, 20.00%
  8. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 20.00%
  9. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 20.00%
  10. Fungal Infection: 2 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ideational apraxia?

Check whether Ideational apraxia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Ideational apraxia:

All the drugs that are associated with Ideational apraxia:

Common conditions associated with Ideational apraxia:

All the conditions that are associated with Ideational apraxia:

How the study uses the data?

The study is based on Ideational apraxia and Acute lymphocytic leukaemia recurrent, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: